Innate and acquired immunity in the pathogenesis of Chagas disease.
about
Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategyHere, There, and Everywhere: The Ubiquitous Distribution of the Immunosignaling Molecule Lysophosphatidylcholine and Its Role on Chagas DiseaseExtracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious DiseasesBAFF mediates splenic B cell response and antibody production in experimental Chagas disease.Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune HomeostasisAcute Chagas disease induces cerebral microvasculopathy in miceInduction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions.Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens.Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human chagas disease.Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi.Lysophosphatidylcholine: A Novel Modulator of Trypanosoma cruzi TransmissionThe Immune Response to Trypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine Development.Trypanosoma cruzi High Mobility Group B (TcHMGB) can act as an inflammatory mediator on mammalian cellsCurcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.Granulocyte colony-stimulating factor partially repairs the damage provoked by Trypanosoma cruzi in murine myocardium.Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development.Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.Influence of environmental enrichment on the behavior and physiology of mice infected by Trypanosoma cruzi.Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1.Electrocardiographic findings in acutely and chronically T. cruzi-infected mice treated by a phenyl-substituted analogue of furamidine DB569.Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity.Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection
P2860
Q24594768-5233A98A-E5D5-4560-99A8-2DC03E8864F2Q26765838-D7AEF727-AB51-48F3-B466-75445259FA19Q26783960-A22E599A-4EDC-4315-8C1D-304F734E9CBBQ33573335-491B2791-E9FF-44CA-9402-D08388A0D3A4Q33729446-F68FE2AF-96BE-4A21-A0DB-EBDE50A923F8Q33881623-24A9E64C-C1CC-4DC5-ABF6-0B8627ACBFFCQ33997924-1E03C2C2-9887-4C96-9A33-E8D237424F41Q34280628-6A9AB2E5-6621-44AF-8562-C972F8D7BC64Q34351157-98046054-66A4-4437-B124-777E523502C2Q35147723-409226B7-59F5-4209-BA85-D7EC4D352B83Q35503605-0A243BF7-C02C-45FE-8102-0986556F163FQ35838023-719029AE-2F12-4A86-BA7C-8ED98164935AQ36274054-A351123B-41A6-457E-BC03-A23373E44F74Q36933422-5C783B53-DDC5-49E2-AF54-48F26E039FD2Q37230882-3A3E7072-0A43-4B54-9E94-50370D972B10Q37593102-2B33B93C-E364-4EB0-A177-C9A73AC58410Q37597066-F44ECD54-A4B5-4E81-8268-929C43803F40Q37788829-A2C9BC36-1851-4DBB-9385-1D9D36F75A4EQ38286350-B254E33D-C1FA-43C8-AF9B-C12CC9EEC336Q38682625-44B79DF2-4BEB-454D-98DB-FF3D21378BBBQ41970393-DEE3391E-AF51-4B03-B0AA-CC111A2F0C79Q42067939-C871BFAB-1FF9-42C5-AA65-71DD66D92147Q42497203-9F143764-3A0E-494F-878F-F9CC106D99C3Q50044327-53F6F69C-5864-4DBD-AF0C-77AE6B4864A6Q58843342-255F5BB9-521E-4731-B6D1-5361A30DAC74
P2860
Innate and acquired immunity in the pathogenesis of Chagas disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Innate and acquired immunity in the pathogenesis of Chagas disease.
@ast
Innate and acquired immunity in the pathogenesis of Chagas disease.
@en
type
label
Innate and acquired immunity in the pathogenesis of Chagas disease.
@ast
Innate and acquired immunity in the pathogenesis of Chagas disease.
@en
prefLabel
Innate and acquired immunity in the pathogenesis of Chagas disease.
@ast
Innate and acquired immunity in the pathogenesis of Chagas disease.
@en
P2860
P1433
P1476
Innate and acquired immunity in the pathogenesis of Chagas disease.
@en
P2093
Denise Golgher
Ricardo T Gazzinelli
P2860
P304
P356
10.1080/08916930410001713115
P577
2004-08-01T00:00:00Z